Long-Term Outcomes of Rheumatoid Arthritis Treatment

Study Overview

An article published in Arthritis & Rheumatology examined the mortality rates, disease activity, and physical function of rheumatoid arthritis (RA) patients over a 20-year span. Rheumatoid arthritis is an autoimmune disorder characterized by joint inflammation and progressive destruction. The effectiveness of Disease Modifying Anti-Rheumatic Drugs (DMARDs) and steroids in managing RA is well-documented. However, limited research has focused on the long-term effects and benefits associated with these treatments.

Research Objectives

The study aimed to determine if the early initiation of DMARDs and steroids could enhance physical function and lower mortality rates in individuals diagnosed with rheumatoid arthritis. A total of 602 patients were recruited between 1990 and 1994. All participants were at least 16 years old and had a minimum of two swollen joints for at least four weeks.

Patient Grouping and Methodology

Patients were categorized based on the timing of their treatment initiation: those who began treatment within six months of symptom onset were classified as early treatment, those who started after six months as late treatment, and those who were never treated. Disease activity, mortality, and physical function were evaluated during the initial visit and subsequently at intervals of 1, 2, 3, 5, 7, 10, 15, and 20 years. Physical function was assessed at each visit using a health assessment questionnaire. Blood samples were collected every five years to measure serum levels of C-reactive protein (CRP), rheumatoid factor (RF), and anti-cyclic citrullinated peptide antibodies (Anti-CCP) for disease activity evaluation.

Key Findings

The results indicated that patients receiving DMARDs and steroids experienced a lower risk of mortality compared to those who did not undergo treatment. Furthermore, patients who started treatment early showed comparable physical function over time to those never treated, while those with late treatment exhibited diminished physical function.

Conclusion

The findings underscore the advantages of using DMARDs and steroids for managing rheumatoid arthritis and emphasize the significance of early treatment initiation for better long-term outcomes.

Author Information

Written by: Karla Sevilla